CD8A and dermatitis: These mice had markedly reduced numbers of circulating CD8+ T cells (Supplemental Figure 14), yet developed dermatitis only slightly delayed compared with non-FTY720–treated drug-challenged mice, who had the ability to recruit T cells to skin from SLOs (Figure 7, B and C).